Publication | Open Access

Multicentre phase I/II study of PI-88, a heparanase inhibitor in combination with docetaxel in patients with metastatic castrate-resistant prostate cancer

UrologyOncologyGenitourinary CancerMedicineHeparanase InhibitorPharmacotherapyCancer TreatmentProstatic DiseasePharmacology